Harbor Investment Advisory’s CONMED CNMD Stock Holding History

Harbor Investment Advisory’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-623	Closed	-$84.7K	–	1218
2023 Q2	$84.7K	Sell	623 -106	-15%	-$12.9K	0.01%	551
2023 Q1	$75.7K	Hold	729	–	–	0.01%	581
2022 Q4	$64.6K	Hold	729	–	–	0.01%	618
2022 Q3	$58K	Buy	729 +144	+25%	+$13.6K	0.01%	640
2022 Q2	$56K	Hold	585	–	–	0.01%	676
2022 Q1	$87K	Sell	585 -52	-8%	-$7.26K	0.01%	577
2021 Q4	$90K	Hold	637	–	–	0.01%	565
2021 Q3	$83K	Hold	637	–	–	0.01%	576
2021 Q2	$88K	Hold	637	–	–	0.01%	541
2021 Q1	$83K	Hold	637	–	–	0.01%	528
2020 Q4	$71K	Buy	637 +191	+43%	+$18.1K	0.01%	535
2020 Q3	$35K	Buy	446 +228	+105%	+$18.6K	0.01%	597
2020 Q2	$16K	Hold	218	–	–	﹤0.01%	685
2020 Q1	$12K	Buy	+218	New	+$20.1K	﹤0.01%	689

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Harbor Investment Advisory's CNMD Position: Q3 2023 in Review

Harbor Investment Advisory sold out of CONMED (CNMD) in Q3 2023, closing a stake of 623 shares — an estimated $84.7K sold.

Harbor Investment Advisory first reported a position in CNMD in Q1 2020 and held it in 14 quarters. The position peaked at $90K in Q4 2021. 274 funds tracked by Wall St. Rank hold CNMD as of Q3 2023.

Harbor Investment Advisory reported no remaining CONMED position as of Q3 2023 after selling out during the quarter.
Harbor Investment Advisory sold 623 CONMED shares in Q3 2023, an estimated $84.7K.
Harbor Investment Advisory first reported a position in CONMED in Q1 2020 and held it in 14 quarters.
Harbor Investment Advisory's CONMED position peaked at $90K in Q4 2021.
274 funds tracked by Wall St. Rank held CONMED as of Q3 2023.

Based on Harbor Investment Advisory's 13F filing for Q3 2023, filed 13 Oct 2023.